4//SEC Filing
Slilaty Steve N. 4
Accession 0001683168-24-001322
CIK 0001402328other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:05 PM ET
Size
4.8 KB
Accession
0001683168-24-001322
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Purchase
Series B Preferred Stock
2024-03-04$0.10/sh+100,000$10,000→ 130,000 total
Documents
Issuer
Sunshine Biopharma, Inc
CIK 0001402328
Entity typeother
Related Parties
1- filerCIK 0001474684
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:05 PM ET
- Size
- 4.8 KB